{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:57:38Z","timestamp":1790827058790,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejps.2014.05.007","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T16:51:12Z","timestamp":1400172672000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Prediction of the in vivo performance of enteric coated pellets in the fasted state under selected biorelevant dissolution conditions"],"prefix":"10.1016","volume":"62","author":[{"given":"M.","family":"\u0160tefani\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vre\u010der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rizmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mrhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bogataj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2014.05.007_b0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2007.06.018","article-title":"A critical evaluation of fasted state simulating gastric fluid (FaSSGF) that contains sodium lauryl sulfate and proposal of a modified recipe","volume":"347","author":"Aburub","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1023\/B:PHAM.0000022404.70478.4b","article-title":"A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions","volume":"21","author":"Blanquet","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.05.007_b0115","unstructured":"Bogataj, M., Cof, G., Mrhar, A., 2010. Peristaltic movement simulating stirring device for dissolution testing, International application published under the PCT, WO 2010\/014046 A1, The International Bureau of WIPO."},{"key":"10.1016\/j.ejps.2014.05.007_b0060","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1211\/jpp.59.10.0007","article-title":"Is bicarbonate buffer suitable as a dissolution medium?","volume":"59","author":"Boni","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2014.05.007_b0105","unstructured":"Burke, M.D., Maheshwari, C.R., Zimmerman, B.O., 2011. Pharmaceutical Analysis Apparatus and Method, U.S. Patent 8,043,270, October 25, 2011."},{"key":"10.1016\/j.ejps.2014.05.007_b0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jps.20495","article-title":"Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model","volume":"95","author":"Carino","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.05.007_b0165","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.chemosphere.2005.09.003","article-title":"Degradation of lansoprazole and omeprazole in the aquatic environment","volume":"63","author":"DellaGreca","year":"2006","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejps.2014.05.007_b0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejps.2009.02.003","article-title":"Simulation of gastric lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach","volume":"37","author":"Diakidou","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.05.007_b0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.05.007_b0170","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1081\/DDC-100102270","article-title":"Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography","volume":"25","author":"Ekpe","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0075","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.05.007_b0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejpb.2008.05.029","article-title":"Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses","volume":"70","author":"Garbacz","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jps.20242","article-title":"Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility","volume":"94","author":"Gu","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2014.05.007_b0085","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.05.007_b0040","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0016-5085(82)90314-6","article-title":"Relationship of motility to flow of contents in the human small intestine","volume":"82","author":"Kerlin","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2014.05.007_b0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1211\/0022357022511","article-title":"Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine","volume":"56","author":"Kostewicz","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2014.05.007_b0175","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1081\/DDC-100101299","article-title":"Preformulation investigation of the novel proton pump inhibitor lansoprazole","volume":"26","author":"Kristl","year":"2000","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0160","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s11095-009-9869-3","article-title":"Gastric emptying of pellets under fasting conditions: a mathematical model","volume":"26","author":"Locatelli","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.05.007_b0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14227\/DT190412P14","article-title":"A formulation case study comparing the dynamic gastric model with conventional dissolution methods","volume":"19","author":"Mann","year":"2012","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.ejps.2014.05.007_b0125","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1021\/mp1001203","article-title":"Dynamic dissolution: a step closer to predictive dissolution testing?","volume":"7","author":"McAllister","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0005","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/mp100149j","article-title":"Physiological parameters for oral delivery and in vitro testing","volume":"7","author":"Mudie","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0030","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0016-5085(90)91150-5","article-title":"The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids","volume":"99","author":"Oberle","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejps.2014.05.007_b0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2010.05.003","article-title":"Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon","volume":"395","author":"Pinto","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0010","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","article-title":"Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging","volume":"22","author":"Schiller","year":"2005","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2014.05.007_b0035","first-page":"G198","article-title":"Relation between fasting antroduodenal motility and transpyloric fluid movements","volume":"257","author":"Schindlbeck","year":"1989","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejps.2014.05.007_b0185","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00228-008-0538-y","article-title":"Proton pump inhibitors: an update of their clinical use and pharmacokinetics","volume":"64","author":"Shi","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2014.05.007_b0130","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1021\/mp100114a","article-title":"Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption","volume":"7","author":"Shi","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejpb.2012.07.011","article-title":"The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro\/in vivo correlation","volume":"82","author":"Stefanic","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0015","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1080\/00365520600610451","article-title":"Effects of posture on the physiology of gastric emptying: a magnetic resonance imaging study","volume":"41","author":"Steingoetter","year":"2006","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejps.2014.05.007_b0180","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3109\/03639049209040850","article-title":"Stabilization of a new antiulcer drug (Lansoprazole) in the solid dosage forms","volume":"18","author":"Tabata","year":"1992","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0055","unstructured":"USP, 1955. The Pharmacopoeia of the United States of America XV."},{"key":"10.1016\/j.ejps.2014.05.007_b0140","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1208\/s12249-011-9616-z","article-title":"Achieving antral grinding forces in biorelevant in vitro models: comparing the USP dissolution apparatus II and the dynamic gastric model with human in vivo data","volume":"12","author":"Vardakou","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2014.05.007_b0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijpharm.2011.07.046","article-title":"Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model","volume":"419","author":"Vardakou","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.05.007_b0050","article-title":"Dissolution controlled drug delivery systems","author":"Wang","year":"2006","journal-title":"Des. Controlled Release Drug Deliv. Syst."},{"key":"10.1016\/j.ejps.2014.05.007_b0190","first-page":"45","author":"Wu-Pong","year":"2005","journal-title":"Appl. Biopharm. Pharmacokinet."},{"key":"10.1016\/j.ejps.2014.05.007_b0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14227\/DT140407P8","article-title":"Simplified biorelevant media for screening dissolution performance of poorly soluble drugs","volume":"14","author":"Zoeller","year":"2007","journal-title":"Dissolut. Technol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714001912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714001912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T13:56:57Z","timestamp":1565445417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098714001912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":37,"alternative-id":["S0928098714001912"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2014.05.007","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of the in vivo performance of enteric coated pellets in the fasted state under selected biorelevant dissolution conditions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2014.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}